Published in Hum Mol Genet on November 15, 2001
Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science (2003) 3.34
A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. Am J Hum Genet (2005) 3.20
Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am J Hum Genet (2004) 2.36
Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet (2004) 1.94
A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet (2004) 1.71
Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet (2004) 1.65
Lack of MEF2A mutations in coronary artery disease. J Clin Invest (2005) 1.62
The Genetic Basis of Type 2 Diabetes. Cellscience (2006) 1.58
Molecular genetics of coronary artery disease. Curr Opin Cardiol (2005) 1.58
Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. Am J Hum Genet (2007) 1.55
Identifying novel genes for atherosclerosis through mouse-human comparative genetics. Am J Hum Genet (2005) 1.46
Genomewide linkage analysis for internal carotid artery intimal medial thickness: evidence for linkage to chromosome 12. Am J Hum Genet (2004) 1.45
GATA2 is associated with familial early-onset coronary artery disease. PLoS Genet (2006) 1.32
From obesity genetics to the future of personalized obesity therapy. Nat Rev Endocrinol (2013) 1.29
Genetic and genomic insights into the molecular basis of atherosclerosis. Cell Metab (2007) 1.27
Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets. Hum Mol Genet (2008) 1.21
MEF2A sequence variants and coronary artery disease: a change of heart? J Clin Invest (2005) 1.10
Variations in Adipokine Genes AdipoQ, Lep, and LepR are Associated with Risk for Obesity-Related Metabolic Disease: The Modulatory Role of Gene-Nutrient Interactions. J Obes (2011) 1.10
Advances in the genetic basis of coronary artery disease. Curr Atheroscler Rep (2005) 1.09
Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. J Hum Genet (2008) 1.09
Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. Hum Genet (2003) 1.08
Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery disease. J Med Genet (2006) 1.02
Structural equation model-based genome scan for the metabolic syndrome. BMC Genet (2003) 1.02
The mouse mahoganoid coat color mutation disrupts a novel C3HC4 RING domain protein. J Clin Invest (2002) 0.97
Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican. Arterioscler Thromb Vasc Biol (2008) 0.95
Multicenter dizygotic twin cohort study confirms two linkage susceptibility loci for body mass index at 3q29 and 7q36 and identifies three further potential novel loci. Int J Obes (Lond) (2009) 0.94
Molecular genetics of myocardial infarction. Genomic Med (2008) 0.91
Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms. Biomark Insights (2009) 0.90
Application of back propagation artificial neural network on genetic variants in adiponectin ADIPOQ, peroxisome proliferator-activated receptor-γ, and retinoid X receptor-α genes and type 2 diabetes risk in a Chinese Han population. Diabetes Technol Ther (2011) 0.88
Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL. Eur J Cancer (2010) 0.87
Search for genetic factors predisposing to atherogenic dyslipidemia. BMC Genet (2003) 0.87
Genomics of heart failure. Heart Fail Clin (2010) 0.87
Genetics talks to epigenetics? The interplay between sequence variants and chromatin structure. Curr Genomics (2010) 0.86
Genetics and cardiovascular disease: Design and development of a DNA biobank. Exp Clin Cardiol (2009) 0.84
Genes, diet and public health. Genes Nutr (2007) 0.83
Association of apolipoprotein A5 gene -1131T>C polymorphism with the risk of metabolic syndrome in Korean subjects. Biomed Res Int (2013) 0.82
The cardio-protective signaling and mechanisms of adiponectin. Am J Cardiovasc Dis (2012) 0.81
Principal-component-based multivariate regression for genetic association studies of metabolic syndrome components. BMC Genet (2010) 0.81
Genetic variation and atherosclerosis. Curr Genomics (2008) 0.79
Identification of shared genetic susceptibility locus for coronary artery disease, type 2 diabetes and obesity: a meta-analysis of genome-wide studies. Cardiovasc Diabetol (2012) 0.79
Association of TRPC1 gene polymorphisms with type 2 diabetes and diabetic nephropathy in Han Chinese population. Endocr Res (2013) 0.78
Genetics of diabetes complications. Mamm Genome (2014) 0.78
Novel KIF6 polymorphism increases susceptibility to type 2 diabetes mellitus and coronary heart disease in Han Chinese men. J Diabetes Res (2014) 0.77
Application of the back-error propagation artificial neural network (BPANN) on genetic variants in the PPAR-γ and RXR-α gene and risk of metabolic syndrome in a Chinese Han population. J Biomed Res (2013) 0.77
Genome-wide linkage scan identifies two novel genetic loci for coronary artery disease: in GeneQuest families. PLoS One (2014) 0.77
Association of adiponectin gene polymorphism with adiponectin levels and risk for insulin resistance syndrome. Int J Prev Med (2015) 0.76
Relation between ADIPOQ gene polymorphisms and type 2 diabetes in a Chinese population. Int J Clin Exp Med (2015) 0.75
High serum level of matrix metalloproteinase 9 and promoter polymorphism - 1562 C:T as a new risk factor for metabolic syndrome. DNA Cell Biol (2014) 0.75
ABCC5 transporter is a novel type 2 diabetes susceptibility gene in European and African American populations. Ann Hum Genet (2014) 0.75
On the significance of linkage studies of complex traits. Am J Hum Genet (2004) 0.75
Genome-Wide Linkage Analysis of Large Multiple Multigenerational Families Identifies Novel Genetic Loci for Coronary Artery Disease. Sci Rep (2017) 0.75
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med (2001) 16.51
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med (2002) 14.15
Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature (1991) 6.17
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature (1998) 5.75
A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52
Genetic associations with human longevity at the APOE and ACE loci. Nat Genet (1994) 4.17
A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet (1998) 4.13
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med (1993) 3.96
Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab (2003) 3.10
Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest (2000) 3.00
Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature (1992) 2.86
Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility. BMJ (2001) 2.74
Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J (Clin Res Ed) (1987) 2.67
Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet (1993) 2.56
Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia (2007) 2.48
A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet (1998) 2.44
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet (1995) 2.29
Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia (2007) 2.23
Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. Nat Genet (1996) 2.09
Non-isotopic and sensitive method for diagnosis of maternally-inherited diabetes and deafness. Diabetologia (1994) 2.03
The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia (2002) 1.99
Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet (1992) 1.95
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ (1988) 1.91
Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest (1999) 1.89
Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med (1995) 1.88
Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J Clin Invest (1998) 1.86
Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA. Genes Brain Behav (2007) 1.86
Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes (1994) 1.85
Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest (1994) 1.82
Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin. DCA 2000 Study Group. Diabetes Metab (1997) 1.82
Dopaminergic polymorphisms associated with self-report measures of human altruism: a fresh phenotype for the dopamine D4 receptor. Mol Psychiatry (2005) 1.77
Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severely obese children. J Pediatr (2001) 1.74
Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest (1997) 1.71
The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet (2000) 1.65
Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabete Metab (1990) 1.64
Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills. Mol Psychiatry (2006) 1.64
Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes (1996) 1.60
Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest (1996) 1.58
Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity. Diabetologia (2000) 1.57
Glucokinase as pancreatic beta cell glucose sensor and diabetes gene. J Clin Invest (1993) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population. Diabetologia (2007) 1.50
Evidence of a non-MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6. Am J Hum Genet (1997) 1.48
Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia (1998) 1.46
Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity. Diabetologia (2005) 1.44
A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet (1997) 1.44
Glucagon secretion in diabetic patients with idiopathic haemochromatosis. Diabetologia (1977) 1.42
Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc Natl Acad Sci U S A (1992) 1.40
Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc Natl Acad Sci U S A (1993) 1.40
Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia (1997) 1.40
Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest (1997) 1.40
A preliminary multicentre study of the treatment of recently diagnosed type 1 diabetes by combination nicotinamide-cyclosporin therapy. Diabet Med (1991) 1.39
A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia (2011) 1.31
Common genetic variation near MC4R is associated with eating behaviour patterns in European populations. Int J Obes (Lond) (2009) 1.30
HNF1alpha controls renal glucose reabsorption in mouse and man. EMBO Rep (2000) 1.29
Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes. J Biol Chem (2001) 1.28
Rapid SNP allele frequency determination in genomic DNA pools by pyrosequencing. Biotechniques (2002) 1.27
The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes. Int J Obes Relat Metab Disord (2000) 1.26
Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease. Diabetes Metab (2000) 1.26
Left ventricular function and hyperthyroidism. Br Heart J (1981) 1.25
beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes (2001) 1.25
Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet (1997) 1.24
Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med (1981) 1.24
Mutations in the glucokinase regulatory protein gene in 2p23 in obese French caucasians. Diabetologia (2003) 1.21
A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat Genet (1995) 1.18
Replication of 13 obesity loci among Singaporean Chinese, Malay and Asian-Indian populations. Int J Obes (Lond) (2011) 1.17
European genetic variants associated with type 2 diabetes in North African Arabs. Diabetes Metab (2012) 1.14
Prevalence of macular pattern dystrophy in maternally inherited diabetes and deafness. GEDIAM Group. Ophthalmology (1999) 1.14
Human genes involved in copy number variation: mechanisms of origin, functional effects and implications for disease. Cytogenet Genome Res (2009) 1.13
Assessment of insulin sensitivity in glucokinase-deficient subjects. Diabetologia (1996) 1.12
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1994) 1.11
Physiologic variations of the internal jugular vein surface, role of the omohyoid muscle, a preliminary echographic study. Surg Radiol Anat (1988) 1.10
Indication for linkage of the human OB gene region with extreme obesity. Diabetes (1996) 1.10
Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young. Eur J Endocrinol (1998) 1.10
Effects of enalapril in insulin-dependent diabetic subjects with mild to moderate uncomplicated hypertension. Diabetes Care (1987) 1.10
Non-sense mutation of glucokinase gene. Lancet (1993) 1.09
Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians. Diabetes (1997) 1.09